<DOC>
	<DOCNO>NCT02823977</DOCNO>
	<brief_summary>This study design evaluate addition ketamine dexmedetomidine adjunctive therapy severe alcohol withdrawal medical ICU patient . Specifically , study ass whether combination ketamine dexmedetomidine reduces dose conventional agent use alcohol withdrawal maintain patient comfort safety explore combination alters expression catecholamine serum time .</brief_summary>
	<brief_title>Ketamine v . Placebo Adjunctive Therapies Severe Alcohol Withdrawal</brief_title>
	<detailed_description>The combination ketamine dexmedetomidine alcohol withdrawal pharmacologically rationale may provide additive benzodiazepine-sparing effect . All subject receive benzodiazepine therapy standard care . The objective randomize , double-blind pilot study 20 subject severe alcohol withdrawal ) determine add ketamine 0.5 mg/kg per hour dexmedetomidine 0.6 µg/kg per hour ( agent administer 72 hour ) adjunctive therapy symptom-triggered benzodiazepine protocol reduces dose requirement conventional sedative maintain patient comfort safety ; b ) explore whether epinephrine , marker autonomic activity , express differently ketamine added dexmedetomidine adjunctive therapy .</detailed_description>
	<mesh_term>Ethanol</mesh_term>
	<mesh_term>Ketamine</mesh_term>
	<mesh_term>Dexmedetomidine</mesh_term>
	<criteria>1 . Severe alcohol withdrawal define CIWA score ≥ 15 need least 16 mg lorazepam equivalent fourhour period . All benzodiazepine barbiturate dos , whether oral intravenous , contribute cumulative amount use follow conversion : 1 mg lorazepam = 2 mg midazolam = 7.5 mg clorazepate = 15 mg phenobarbital . 2 . Patients receive standard therapy severe alcohol withdrawal accord UCHspecific , symptomtriggered alcohol withdrawal protocol ICU ( admission ICU anticipate ) . Lorazepam prefer benzodiazepine agent patient require ICU admission due alcohol withdrawal . 3 . Informed consent within 36 hour qualify study . 1 . Patients &lt; 18 year age &gt; 85 year age . 2 . Patients receive benzodiazepine therapy purpose alcohol withdrawal ( e.g . sedation , seizure control alcohol withdrawal ) . 3 . Patients alcohol withdrawal require ICU admission . 4 . Patients receive epidural administration medication ( ) . 5 . Comatose patient metabolic neurologic affectation . 6 . Patients active myocardial ischemia second thirddegree heart block . 7 . Patients ChildPugh score C. 8 . Moribund state plan withdrawal life support . 9 . Patient pending transfer another facility . 10 . Patients know suspect severe adverse reaction dexmedetomidine ( clonidine ) ketamine . 11 . Pregnant female female suspect pregnant . 12 . Prisoners active parolee . 13 . Previous study participation . 14 . Patients already receive ketamine alcohol withdrawal . Patients receive dexmedetomidine exclude infusion exceed 1 µg/kg per hour two hour rate cumulative duration 12 hour .</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>85 Years</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>ketamine</keyword>
	<keyword>dexmedetomidine</keyword>
	<keyword>alcohol</keyword>
</DOC>